Project Number 1R01AG047922-01 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for ACTIVE IMMUNOTHERAPY FOR COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator RAFII, MICHAEL S Principal Investigator First Name MICHAEL Principal Investigator Last Name RAFII Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-11-100: Alzheimer's Disease Pilot Clinical Trials (R01) FY Overall Cost $826,451 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Special Initiative Special Research Focus: Down Syndrome Related Resources Clinical Trial Safety; Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
